{"organizations": [], "uuid": "4f6bf76e904229d42130790b8c60b6bd43c8c43f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/5", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/26/globe-newswire-collegium-to-host-conference-call-to-discuss-fourth-quarter-2017-financial-results-and-provide-corporate-update.html", "country": "US", "domain_rank": 767, "title": "Collegium to Host Conference Call to Discuss Fourth Quarter 2017 Financial Results and Provide Corporate Update", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.018, "site_type": "news", "published": "2018-02-27T00:01:00.000+02:00", "replies_count": 0, "uuid": "4f6bf76e904229d42130790b8c60b6bd43c8c43f"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/26/globe-newswire-collegium-to-host-conference-call-to-discuss-fourth-quarter-2017-financial-results-and-provide-corporate-update.html", "ord_in_thread": 0, "title": "Collegium to Host Conference Call to Discuss Fourth Quarter 2017 Financial Results and Provide Corporate Update", "locations": [], "entities": {"persons": [], "locations": [{"name": "mass.", "sentiment": "none"}, {"name": "canton", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "collegium pharmaceutical, inc.", "sentiment": "neutral"}, {"name": "company", "sentiment": "none"}, {"name": "collegium pharmaceutical, inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "CANTON, Mass., Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, March 7, 2018 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update.\nConference Call Information:\nTo access the conference call, please dial (888) 698-6931 (U.S.) or (805) 905-2993 (International) and refer to Conference ID: 764-8078. An audio webcast will be accessible from the Investor Relations section of the Company’s website: http://www.collegiumpharma.com/ . An archived webcast will be available on the Company’s website approximately two hours after the event.\nAbou t Collegium Pharmaceutical, Inc.\nCollegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its proprietary DETERx ® technology platform for the treatment of chronic pain and other diseases. The DETERx technology platform is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.\nAbout Xtampza ER\nXtampza ® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the FDA for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.\nContact:\nAlex Dasalla\nadasalla@collegiumpharma.com\nSource:Collegium Pharmaceutical, Inc.", "external_links": ["http://www.collegiumpharma.com/", "https://www.globenewswire.com/Tracker?data=XwYwVaeb9ZACTUi0mO5TIV3iHkV5pxfMgwgM5SlrrwUjLxBR9xuIM4VIkOb2CgcK8cZ8zbDEUA3k3Cu08PeUJt96aekXJAQov4CXx8MR9Wm1MJtO_IU2-Hyrh5wWJgmk", "https://www.globenewswire.com/NewsRoom/AttachmentNg/4853d47c-93af-4b27-b908-3ba4856f9c1d", "https://www.globenewswire.com/Tracker?data=T9KXRc4GLyE1eFRgivw2xkAmrWrIiIDQJdSMh3-IIiB_mlrYWwPa7SXZSPmrKcyYBOqQlTqIEdTQV5qOl2Ovay8j4fDbsu8xPBCGWfH86eWipVHKEejJMyAXEoiuVxjl"], "published": "2018-02-27T00:01:00.000+02:00", "crawled": "2018-02-27T00:58:14.002+02:00", "highlightTitle": ""}